Mon. Nov 28th, 2022
JJ#39;s pause on late stage clinical trial of COVID-19 vaccine raises concerns While serious adverse event are not uncommon in clinical trials, they raise concerns, especially when the vaccine development timelines are compressed, leaving less time to sufficiently analyse safety and efficacy of the drug or vaccine